title: Special Issue in Honor of Robert B. Nussenblatt, MD, MPH.
authors.affiliation: 1 Laboratory of Immunology, National Eye Institute, National Institutes of Health , Bethesda, Maryland.|2 Zhongshan Ophthalmic Center, Sun Yat-sen University , Guangzhou, China .
authors.forename: Chi-Chao
authors.initials: CC
authors.lastname: Chan
authors.affiliation: 3 The Eye Center and The Eye Foundation for Research in Ophthalmology , Riyadh, Saudi Arabia .|4 Department of Ophthalmology, College of Medicine, King Saud University , Riyadh, Saudi Arabia .|5 The Wilmer Ophthalmological Institute of The Johns Hopkins University School of Medicine , Baltimore, Maryland.
authors.forename: Khalid F
authors.initials: KF
authors.lastname: Tabbara
authors.affiliation: 1 Laboratory of Immunology, National Eye Institute, National Institutes of Health , Bethesda, Maryland.
authors.forename: H Nida
authors.initials: HN
authors.lastname: Sen
mesh_terms: D016572:Cyclosporine / Q000627:therapeutic use; D005128:Eye Diseases / Q000276:immunology*; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D054554:National Eye Institute (U.S.) / Q000458:organization & administration; D000072163:Ophthalmologists / Q000266:history*; D010820:Physicians / Q000266:history*; D013601:T-Lymphocytes / Q000187:drug effects; D014481:United States; D014605:Uveitis / Q000188:drug therapy
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine